These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18181252)

  • 1. Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography.
    Anderer P; Saletu B; Wolzt M; Culic S; Assandri A; Nannipieri F; Rosini S; Saletu-Zyhlarz GM
    Hum Psychopharmacol; 2008 Apr; 23(3):243-54. PubMed ID: 18181252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
    Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
    Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Saletu B; Zeitlhofer J
    Sleep Med; 2009 Sep; 10(8):850-8. PubMed ID: 19342295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography).
    Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():121-37. PubMed ID: 12575494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
    Anderer P; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Pascual-Marqui RD
    Neuropsychobiology; 2004; 49(3):134-53. PubMed ID: 15034229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
    Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
    Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials.
    Anderer P; Saletu B; Gruber D; Linzmayer L; Semlitsch HV; Saletu-Zyhlarz G; Brandstätter N; Metka M; Huber J
    Maturitas; 2005 Jul; 51(3):254-69. PubMed ID: 15978969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugs.
    Anderer P; Saletu B; Semlitsch HV; Pascual-Marqui RD
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():85-91. PubMed ID: 12575474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic potency of a new anticonvulsant drug versus acetylsalicylic acid via laser somatosensory evoked potentials. Randomized placebo-controlled double-blind (5-way) crossover study.
    Schaffler K; Wauschkuhn CH; Gierend M
    Arzneimittelforschung; 1991 Apr; 41(4):427-35. PubMed ID: 1859518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures.
    Papadopoulos A; Rich A; Nutt DJ; Bailey JE
    J Psychopharmacol; 2010 May; 24(5):649-56. PubMed ID: 18832434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid supplementation decreases P300 latency and increases P300 amplitude of event-related potentials in healthy elderly men.
    Ishikura Y; Ikeda G; Akimoto K; Hata M; Kusumoto A; Kidokoro A; Kontani M; Kawashima H; Kiso Y; Koga Y
    Neuropsychobiology; 2009; 60(2):73-9. PubMed ID: 19752581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a small dose of triazolam on P300.
    Hayakawa T; Uchiyama M; Urata J; Enomoto T; Okubo J; Okawa M
    Psychiatry Clin Neurosci; 1999 Apr; 53(2):185-7. PubMed ID: 10459684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the new antiepileptic drug rufinamide on cognitive functions.
    Aldenkamp AP; Alpherts WC
    Epilepsia; 2006 Jul; 47(7):1153-9. PubMed ID: 16886978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cortisol on the laterality of the neural correlates of episodic memory.
    Alhaj HA; Massey AE; McAllister-Williams RH
    J Psychiatr Res; 2008 Oct; 42(12):971-81. PubMed ID: 18187154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
    de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
    J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study.
    Collie A; Darekar A; Weissgerber G; Toh MK; Snyder PJ; Maruff P; Huggins JP
    Contemp Clin Trials; 2007 Jul; 28(4):391-400. PubMed ID: 17267292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.